Korea Pharmacy Co. Ltd. (032300.KQ) stock: key figures, P/E, revenue and dividend
Energy · Coal & Consumable Fuels · South Korea
Korea Pharmacy Co. Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 81.28 bn KRW | 87.60 bn KRW |
| Gross profit | 35.17 bn KRW | 31.40 bn KRW |
| Operating income | 7.56 bn KRW | -887.33 m KRW |
| EBIT | 6.79 bn KRW | -955.22 m KRW |
| Net income | 3.79 bn KRW | -2.64 bn KRW |
| Diluted EPS – continuing operations | 347.65 KRW | -242.09 KRW |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Korea Pharmacy Co. Ltd.
KOREA PHARMA Co., Ltd. . produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea.
More stocks
- Acrivon Therapeutics, Inc. (ACRV)
- NETSOL TECHNOLOGIES INC (NTWK)
- Concorde International Group Ltd Class A Ordinary Shares (CIGL)
- WRAP TECHNOLOGIES, INC. (WRAP)
- Richmond International Travel & Tours Co Ltd (2743.TWO)
- Sangsangin Investment & Securities Co Ltd (001290.KS)
- MAIA Biotechnology, Inc. (MAIA)
- Crown Confectionery Co Ltd (264900.KS)
- Viskase Holdings, Inc. (VISK)
- WASGAU Produktions & Handels AG (MSH.F)
- Union Auction Public Company Limited (AUCT.BK)
- Wavice Inc. (289930.KQ)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.